Stay updated on Amivantamab Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.

Latest updates to the Amivantamab Clinical Trial in Advanced NSCLC page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe change represents an incremental platform update from v3.6.3 to v3.6.4. There is no indication of changes to the trial information or page layout.SummaryDifference0.0%

- Check18 days agoChange DetectedA CHRYSALIS-related publication citation has been added to the Publications section, expanding the literature cited for Amivantamab in NSCLC. The change does not modify study details or reporting on the page.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded July 2026 update dates to the page's update history (2026-07-06, 2026-07-02, 2026-07) and removed June 2026 dates (2026-06-05, 2026-06-04, 2026-06).SummaryDifference0.1%

- Check32 days agoChange DetectedA new reference about amivantamab-related cutaneous toxicities has been added to the page. The page revision tag has been updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check39 days agoChange DetectedThe study page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page. This change represents an internal update to the page version rather than a substantive alteration to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now shows recruitment has ended ('No longer looking for participants'), affecting enrollment on the study page. It also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study), updates the Intervention/Treatment heading formatting, and notes the site revision to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Amivantamab Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.